Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Johnson and Johnson
Baxter
Merck
Cantor Fitzgerald
Healthtrust
Fuji
Colorcon
Chubb

Generated: April 19, 2018

DrugPatentWatch Database Preview

Ciprofloxacin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for ciprofloxacin hydrochloride and what is the scope of ciprofloxacin hydrochloride patent protection?

Ciprofloxacin hydrochloride
is the generic ingredient in seven branded drugs marketed by Novartis Pharms Corp, Akorn Inc, Amring Pharms, Apotex Inc, Fdc Ltd, Rising Pharms Inc, Teligent, Watson Labs Inc, Wraser Pharms, Depomed Inc, Bayer Hlthcare, Apotex, Aurobindo Pharma, Barr, Carlsbad, Dr Reddys Labs Ltd, Fosun Pharma, Hikma, Idt Australia Ltd, Ivax Sub Teva Pharms, Mylan, Nostrum Labs, Pliva, Sun Pharm Inds Ltd, Taro Pharm, Teva, Unique Pharm Labs, Watson Labs, and Laboratorios Salvat, and is included in thirty-two NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ciprofloxacin hydrochloride has nineteen patent family members in fourteen countries.

There are thirty-one drug master file entries for ciprofloxacin hydrochloride. Seventy-three suppliers are listed for this compound. There are two tentative approvals for this compound.
Summary for ciprofloxacin hydrochloride
Pharmacology for ciprofloxacin hydrochloride
Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial
Synonyms for ciprofloxacin hydrochloride
0MP32MFP6C
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid HCl
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid hydrochloride
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid monohydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylicacidhydrochloride
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid; hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-piperazinylhydroquinoline-3-carboxylic acid, ch loride
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrochloride
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, monohydrochloride
3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-, hydrochloride
4-(3-Carboxy-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-quinolin-7-yl)-piperazin-1-ium; chloride
86483-48-9
93107-08-5
9311AF
AC-23972
AC1L1Y6P
AC1Q3E6U
AK126819
AK176012
AKOS005111008
AN-35553
API0002028
ARONIS24122
AX8035163
BAY-o 9867
BAY-O-9867
Bay-o-9867 monohydrate
BB_SC-1870
BBC/258
BG0142
BIM-0048462.P001
C17H18FN3O3.HCl
Cambridge id 5807784
CAS-93107-08-5
Cetraxal
CHEBI:310388
CHEMBL1202
Cipro
Ciprofloxacin HCl
CIPROFLOXACIN HCL/LACTATE
ciprofloxacin hydrochloride (anh.)
ciprofloxacin hydrochloride (anhydrous)
Ciprofloxacin Hydrochloride Anhydrous
Ciprofloxacin monohydrochloride
ciprofloxacine hydrochloride
Ciprofloxacinhydrochloride
CS-8134
DIOIOSKKIYDRIQ-UHFFFAOYSA-N
DSSTox_CID_27768
DSSTox_GSID_47788
DSSTox_RID_82545
DTXSID1047788
Epitope ID:174846
F0001-2378
FT-0623850
FT-0623851
GP9406
HE064945
HMS1568G08
HY-B0356A
KB-218801
KS-000046JK
KS-5012
LS-141564
MFCD00079044
MolPort-002-338-774
NCGC00016959-01
NCGC00016959-06
NSC-620634
NSC620634
Prestwick_67
Q-200860
SBB080619
SC-12658
SCHEMBL42310
Tox21_110712
Tox21_110712_1
UNII-0MP32MFP6C
Z-0831
ZX-AS004472
Tentative approvals for CIPROFLOXACIN HYDROCHLORIDE
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free TrialEQ 250MG BASETABLET;ORAL
➤ Try a Free Trial➤ Try a Free TrialEQ 750MG BASETABLET;ORAL
➤ Try a Free Trial➤ Try a Free TrialEQ 500MG BASETABLET;ORAL

US Patents and Regulatory Information for ciprofloxacin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride SOLUTION/DROPS;OPHTHALMIC 076754-001 Jun 9, 2004 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Idt Australia Ltd CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 075939-002 Jun 9, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076136-001 Jun 9, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Idt Australia Ltd CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 075939-004 Jun 9, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ciprofloxacin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis Pharms Corp CILOXAN ciprofloxacin hydrochloride OINTMENT;OPHTHALMIC 020369-001 Mar 30, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for ciprofloxacin hydrochloride

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0012 France ➤ Try a Free Trial PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
C/GB12/058 United Kingdom ➤ Try a Free Trial PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Julphar
Moodys
Harvard Business School
Fuji
Deloitte
AstraZeneca
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.